| Comunicazioni selezionate | ||||
| A01 | Bisordi | Duccio | Pisa | Relationship between periodontal disease and medical osteonecrosis of the jaw |
| A03 | Cabras | Marco | Torino | MEDICATION-RELATED OSTEONECROSIS OF JAW (MR-ONJ) IN OSTEOPOROSIS PATIENTS: RECENT EXPERIENCE DATA FROM PIEMONTE – VALLE D’AOSTA |
| B11 | Ghidini | Giulia | Parma | Er:YAG laser for bone vaporization and Auto-Fluorescence as a guide in highlighting surgical margins: a new surgical approach. |
| B16 | Tommasi Luigi | Migliario Mario | Alessandria-Novara | OSTEONECROSIS OF JAW AFTER SUNITINIB AND DENOSUMAB: WHEN BONE SCAN IS MORE SENSIBLE THAN COMPUTED TOMOGRAPHY. A CASE REPORT |
| C03 | Bonacina | Riccardo | Bergamo | THE IMPORTANCE OF PREVENTIVE DENTAL PROCEDURES STRATEGIES REDUCING THE RISK OF BRONJ IN CANCER PATIENTS WITH BONE METASTASIS: A SINGLE CENTER EXPERIENCE. |
| C10 | Oteri | Giacomo | Messina | Lack of adherence to periodontal supportive therapy in oncological patients treated with bone targeting agents. Do it play a role in ONJ development? |
| D07 | Ghidini | Giulia | Parma | Early treatment of Medication-related osteonecrosis of the jaws: comparison between surgical and non-surgical approach. |
| D10 | Campolongo | Martin Giorgio | Orbassano | MRONJ: presence of suppuration as a prognostic factor for surgical interventions. |
| E01 | Basano | Lorenzo | Torino Mauriz | SPECT-CT vs CT in identifying MRONJ-affected bone. Correlation with surgical and histopathological findings. Preliminary results. |
| E02 | Floreno | Manuele | Torino | Radiological differences among ONJ patients affected from ONJ and negative patients under use of endovenous bisphosphonates |
| E03 | Salimian | Nick | Padova | Validation of prognostic impact of CT in medication-related osteonecrosis of the jaw: a longitudinal study |
| Attestato di merito | ||||
| A09 | Panari | Lucia | Modena | Retrospective analysis of BP therapy in 1663 oncological and hematological patients between 2007 and 2016. Effect of dental prevention on ONJ incidence. |
| A11 | Pizzo | Alessio | Parma | Prevalence of mandibular fracture among 328 patients with medication-related osteonecrosis of jaws (MRONJ) |
| B15 | Mauceri | rodolfo | Palermo | Surgical treatment of medication-related osteonecrosis of the jaws with addiction of L-PRF: preliminary results. |
| B17 | Montori | Alessandra | Roma | L-PRF AND LLLT as adjuvant treatments in MRONJ: case series |
| C06 | Maniscalco | Laura | Palermo | A statistical evaluation of risk factors related to ONJ onset: a retrospective survey. |
| C08 | Mauceri | rodolfo | Palermo | Development of OloHealth, a teledentistry platform for the ONJ prevention in Sicily: preliminary reports. |
| D09 | Mariotti | Stefania | Pisa | Conservative surgical treatment of Medical Related Osteonecrosis of the Jaw: experience of a single institution |
| D12 | TESEI | Andrea | Ancona | Effect of leukocyte and platelet-rich fibrin (L-PRF) on the treatment of BRONJ |
| E04 | Tommasi | Luigi | Alessandria | ROLE OF NUCLEAR MEDICINE IMAGING TECHNIQUES IN EARLY DIAGNOSIS OF ONJ IN PROSTATE CANCER PATIENTS: REPORT OF A DEMONSTRATIVE CASE |
| E05 | Della Ferrera | Francesco | Torino Mauriz | Oral bisphosphonates; patients’ lack of knowledge could increase MRONJ risk. Surgical management improved with the aid of SPECT-CT |
| Premio per i poster | ||||
| A03 | Majlinda Caka | Austa Marco | Asti | Clinical course and therapeutic outcomes in medication-related osteonecrosis of the jaw. Our experience in the last two years. |
| A02 | Broccardo | Emanuele | Novara | Ten-years of clinical experience in medication-related osteonecosis of the jaw. |
| A12 | Canicattì Manuela | Testore Franco | Asti | DENOSUMAB RELATED OSTEONECROSIS OF JAW : A SINGLE CENTRE FIVE-YEAR EXPERIENCE |
| B03 | Bosso | Ilaria | Torino | MRONJ around fixtures: clinical aspects, treatment and outcome in 6 patients. |
| B01 | Antonelli | Alessandro | Catanzaro | Use of autologous platelet-rich fibrin (A-PRF and i-PRF) in the treatment of a massive medication-related osteonecrosis of the jaw (MRONJ |
| B09 | Gallo | Vincenzo | Torino | Multifocal MRONJ: a report of six cases |
| B12 | Giarracca | Carlo | Torino | Stage III Medication-Related Osteonecrosis in patients treated with oral-bisphosphonate: 4 Case Reports |
| B07 | Feraboli | Liliana | Bologna | Platelet Rich Fibrin (PRF) Vivostat as a possible alternative for MRONJ treatment: a case report. |
| B10 | Gaudino | Erica | Ivrea | An unusual case of osteonecrosis of the jaw in a renal cell carcinoma patient treated with sunitinib alone. |
| C07 | Viganò Raffaello | Casu Cinzia | Varese-Cagliari | B.P.F.C.® Bio-Plasma® with Pure Growth Factors (BioPlasma®) for the surgical treatment of patients at risk of maxillary osteonecrosis, related to bisphosphonates (BRONJ) |
| C09 | Pergolini | Daniele | Roma | Is the Presence of dental implants a local risk factor for MRONJ? |
| D02 | Del Fabbro | Massimo | Milano | Autologous platelet concentrates for treatment and prevention of medication-related osteonecrosis of the jaw (MRONJ). A systematic review of the literature |
| D05 | Ronzino | Francesca | Milano San Raffaele | Low-level laser therapy in the treatment of osteonecrosis of the jaws: prospective study |
| D11 | Viganò Raffaello | Casu Cinzia | Varese-Cagliari | B.P.F.C.® Bio-Plasma® with Pure Growth Factors (BioPlasma®) for the treatment of maxillary osteonecrosis, related to bisphosphonates (BRONJ) |
| D04 | Brega | Monica | Torino | Stage III Medication-Related Osteonecrosis of the Posterior Maxilla: Surgical Treatment Using a Pedicled Buccal Fat Pad Flap: five Case Reports |